$11.7B
$350,000
0.0% of portfolio
5,623
Q3 2024
Reduced 41.88%
-
$450,000
0.0% of portfolio
-
Q3 2024
Added 109.67%
$27.9B
$651,000
0.0% of portfolio
35,212
Q3 2024
Added 25.43%
$22.1B
$901,000
0.0% of portfolio
5,525
Q3 2024
Added 42.58%
$6.72B
$391,000
0.0% of portfolio
8,015
Q3 2024
Added 22.11%
$15.1B
$1.97 Million
0.0% of portfolio
19,709
Q3 2024
Added 0.75%
Halozyme Therapeutics Inc
-
$650,000
0.0% of portfolio
-
Q1 2024
Reduced 60.61%
$6.57B
$585,000
0.0% of portfolio
49,403
Q3 2024
Added 22.1%
$8.78B
$1.74 Million
0.0% of portfolio
64,856
Q3 2024
Reduced 71.67%
$1.11B
$918,000
0.0% of portfolio
406,215
Q3 2024
Reduced 17.15%
$0
$1.24 Million
0.0% of portfolio
12,265
Q3 2024
Added 22.32%
$0
$1.22 Million
0.0% of portfolio
9,741
Q3 2024
Added 18.78%
$19.9B
$1.53 Million
0.0% of portfolio
21,599
Q3 2024
Reduced 12.21%
$3.52B
$208,000
0.0% of portfolio
14,032
Q3 2024
Reduced 4.64%
$0
$878,000
0.0% of portfolio
3,775
Q3 2024
New
$8.62B
$396,000
0.0% of portfolio
2,467
Q3 2024
Added 38.52%
$20.9B
$982,000
0.0% of portfolio
20,101
Q3 2024
Added 5.59%
$94.9B
$991,000
0.0% of portfolio
7,593
Q3 2024
Added 6.78%
$175B
$976,000
0.0% of portfolio
8,059
Q3 2024
Reduced 2.39%
$3.3B
$218,000
0.0% of portfolio
12,401
Q3 2024
Reduced 26.29%
$15.9B
$1.51 Million
0.0% of portfolio
130,135
Q3 2024
Reduced 38.24%
$6.7B
$1.19 Million
0.0% of portfolio
111,725
Q3 2024
Reduced 57.79%
$8.04B
$424,000
0.0% of portfolio
1,500
Q2 2024
Reduced 51.61%
-
$685,000
0.0% of portfolio
-
Q1 2024
Reduced 38.46%
-
$241,000
0.0% of portfolio
-
Q3 2024
New
$18.7B
$248,000
0.0% of portfolio
3,347
Q3 2024
New
$2.56B
$956,000
0.0% of portfolio
84,900
Q3 2024
New
$16.9B
$773,000
0.0% of portfolio
2,747
Q3 2024
Reduced 15.48%
$60.7B
$491,000
0.0% of portfolio
16,602
Q3 2024
New
$25.1B
$1.28 Million
0.0% of portfolio
32,766
Q3 2024
Added 17.77%
$22.9B
$1.03 Million
0.0% of portfolio
659
Q3 2024
Reduced 27.58%
$11B
$418,000
0.0% of portfolio
20,385
Q3 2024
Added 33.07%
$23.3B
$809,000
0.0% of portfolio
4,819
Q3 2024
Reduced 17.97%
$10.8B
$889,000
0.0% of portfolio
44,126
Q3 2024
Added 1.44%
$13.1B
$1.51 Million
0.0% of portfolio
30,910
Q3 2024
Reduced 18.43%
$7.92B
$436,000
0.0% of portfolio
24,843
Q3 2024
Added 51.54%
$16.6B
$1.2 Million
0.0% of portfolio
4,166
Q3 2024
Added 19.61%
$39.4B
$1.87 Million
0.0% of portfolio
16,281
Q3 2024
Added 18.38%
$7.01B
$1.01 Million
0.0% of portfolio
56,200
Q3 2024
New
$5.65B
$1.92 Million
0.0% of portfolio
20,631
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2023
Reduced 5.77%
$8.87B
$831,000
0.0% of portfolio
41,443
Q3 2024
Reduced 2.01%
$33.9B
$409,000
0.0% of portfolio
222
Q3 2024
Reduced 44.22%
$14.1B
$1.9 Million
0.0% of portfolio
171,493
Q3 2024
Reduced 23.72%
$23.9B
$289,000
0.0% of portfolio
6,522
Q2 2024
Reduced 6.2%
$31.1B
$721,000
0.0% of portfolio
7,304
Q3 2024
Reduced 13.09%
$7.5B
$657,000
0.0% of portfolio
25,646
Q3 2024
Reduced 45.93%
$58.7B
$331,000
0.0% of portfolio
5,390
Q3 2024
New
Ionis Pharmaceuticals Inc
-
$495,000
0.0% of portfolio
-
Q1 2024
New
$21.4B
$1.58 Million
0.0% of portfolio
25,633
Q3 2024
Added 7.74%